» Authors » Michal Kunicki

Michal Kunicki

Explore the profile of Michal Kunicki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 386
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kunicki M, Rzewuska N, Soponska P, Pawlosek A, Sowinska I, Kloska A
Gynecol Endocrinol . 2025 Jan; 41(1):2455472. PMID: 39834324
Gestational diabetes mellitus (GDM) affects 9-25% of pregnancies. Undiagnosed or poorly managed GDM is associated with both short- and long-term complications in the fetus and mother. The pathogenesis of GDM...
2.
Karpowicz N, Maczka K, Skoczylas A, Pacocha N, Kunicki M, Grymowicz M, et al.
J Family Reprod Health . 2024 Oct; 18(3):170-179. PMID: 39439736
Objective: Over the decade, variety and effectiveness of contraception methods have greatly improved, resulting in increased popularity of oral contraceptive pills (OCPs). However, hormonal contraception carries the risk of multiple...
3.
Kunicki M, Fulnecek J, Rozga P
Sensors (Basel) . 2024 Sep; 24(18). PMID: 39338744
The adequate technical condition assessment of key apparatuses is a crucial assumption in the delivery of reliable and continuous electric power to customers [...].
4.
Liss J, Kuczynska M, Kunicki M, Zielinski K, Drzyzga D
Sci Rep . 2024 May; 14(1):11689. PMID: 38778076
We evaluated whether serum stem cell factor (s-SCF) levels just prior to ovulation induction could indicate the ability to develop a top-quality (TQ) blastocyst by day 5. We investigated patients...
5.
Kunicki M, Rzewuska N, Gross-Kepinska K
J Reprod Immunol . 2024 May; 164:104253. PMID: 38776714
Premature Ovarian Insufficiency (POI), also known as Premature Ovarian Failure (POF), is a heterogeneous disorder characterized by the cessation of ovarian function before age 40. Clinical symptoms include menstrual disorders:...
6.
Zielinski K, Kloska A, Wygocki P, Zielen M, Kunicki M
J Assist Reprod Genet . 2024 Apr; 41(6):1557-1567. PMID: 38573535
Purpose: Ovarian stimulation with gonadotropins is crucial for obtaining mature oocytes for in vitro fertilization (IVF). Determining the optimal gonadotropin dosage is essential for maximizing its effectiveness. Our study aimed...
7.
Rzewuska N, Kunicki M, Mechsner S, Kordowitzki P
Aging Dis . 2023 Nov; 15(6):2361-2368. PMID: 37962456
Endometriosis affects 2-5 % of postmenopausal women with menopause hormone therapy and is less common in women without treatment with exogenous estrogen or tamoxifen. Postmenopausal endometriosis has more unknown aspects...
8.
Kunicki M, Borucki S, Fulnecek J
Sensors (Basel) . 2023 Nov; 23(21). PMID: 37960384
This paper presents an alternative approach to the Transformer Assessment Index (TAI) by proposing a relatively simple rating method called the Exploitation Perspective Index (EPI). The method provides two numerical...
9.
Rzewuska N, Kunicki J, Pieniak K, Laskus P, Zabielska B, Smolarczyk R, et al.
Eur J Obstet Gynecol Reprod Biol . 2023 Nov; 292:1-7. PMID: 37948928
Background: A few publications have examined the frequency and medical implications of individuals with idiopathic intracranial hypertension (IIH) and polycystic ovarian syndrome (PCOS), but the findings have been inconclusive. IIH...
10.
Zielinski K, Drabczyk D, Kunicki M, Drzyzga D, Kloska A, Ruminski J
Reprod Biol Endocrinol . 2023 Oct; 21(1):102. PMID: 37898817
Background: Endometriosis is a condition that significantly affects the quality of life of about 10 % of reproductive-aged women. It is characterized by the presence of tissue similar to the...